Association of glycation gap with mortality and vascular complications in diabetes
- PMID: 23835697
- PMCID: PMC3781552
- DOI: 10.2337/dc12-1040
Association of glycation gap with mortality and vascular complications in diabetes
Abstract
Objective: The "glycation gap" (G-gap), an essentially unproven concept, is an empiric measure of disagreement between HbA1c and fructosamine, the two indirect estimates of glycemic control. Its association with demographic features and key clinical outcomes in individuals with diabetes is uncertain.
Research design and methods: The G-gap was calculated as the difference between measured HbA1c and a fructosamine-derived standardized predicted HbA1c in 3,182 individuals with diabetes. The G-gap's associations with demographics and clinical outcomes (retinopathy, nephropathy, macrovascular disease, and mortality) were determined.
Results: Demographics varied significantly with G-gap for age, sex, ethnic status, smoking status, type and duration of diabetes, insulin use, and obesity. A positive G-gap was associated with retinopathy (odds ratio 1.24 [95% CI 1.01-1.52], P=0.039), nephropathy (1.55 [1.23-1.95], P<0.001), and, in a subset, macrovascular disease (1.91 [1.18-3.09], P=0.008). In Cox regression analysis, the G-gap had a "U"-shaped quadratic relationship with mortality, with both negative G-gap (1.96 [1.50-2.55], P<0.001) and positive G-gap (2.02 [1.57-2.60], P<0.001) being associated with a significantly higher mortality.
Conclusions: We confirm published associations of G-gap with retinopathy and nephropathy. We newly demonstrate a relationship with macrovascular and mortality outcomes and potential links to distinct subpopulations of diabetes.
Figures
Similar articles
-
Glycation gap is associated with macroproteinuria but not with other complications in patients with type 2 diabetes.Diabetes Care. 2013 Jul;36(7):2070-6. doi: 10.2337/dc12-1780. Epub 2013 Feb 1. Diabetes Care. 2013. PMID: 23378625 Free PMC article.
-
Progression of nephropathy in type 2 diabetes: the glycation gap is a significant predictor after adjustment for glycohemoglobin (Hb A1c).Clin Chem. 2011 Feb;57(2):264-71. doi: 10.1373/clinchem.2010.144949. Epub 2010 Dec 8. Clin Chem. 2011. PMID: 21147957
-
Discordance between HbA1c and fructosamine: evidence for a glycosylation gap and its relation to diabetic nephropathy.Diabetes Care. 2003 Jan;26(1):163-7. doi: 10.2337/diacare.26.1.163. Diabetes Care. 2003. PMID: 12502674
-
Long-term Glycemic Variability and Risk of Adverse Outcomes: A Systematic Review and Meta-analysis.Diabetes Care. 2015 Dec;38(12):2354-69. doi: 10.2337/dc15-1188. Diabetes Care. 2015. PMID: 26604281 Review.
-
Effects comparison between low glycemic index diets and high glycemic index diets on HbA1c and fructosamine for patients with diabetes: A systematic review and meta-analysis.Prim Care Diabetes. 2015 Oct;9(5):362-9. doi: 10.1016/j.pcd.2014.10.008. Epub 2014 Dec 16. Prim Care Diabetes. 2015. PMID: 25524422 Review.
Cited by
-
Determinants of mortality in patients with type 2 diabetes: a review.Rev Endocr Metab Disord. 2016 Mar;17(1):129-37. doi: 10.1007/s11154-016-9349-0. Rev Endocr Metab Disord. 2016. PMID: 27068710 Review.
-
The Correlation Between Glycation Gap and Renal Complications in Patients with Type 2 Diabetes Mellitus.Diabetes Metab Syndr Obes. 2024 Jan 23;17:333-341. doi: 10.2147/DMSO.S439800. eCollection 2024. Diabetes Metab Syndr Obes. 2024. PMID: 38283633 Free PMC article.
-
Comparative Study of Azithromycin Versus Doxycycline Effect on the Resistin Level in Periodontitis Patients With Type 2 Diabetes: A Randomized Controlled Clinical Trial.Cureus. 2024 Feb 25;16(2):e54849. doi: 10.7759/cureus.54849. eCollection 2024 Feb. Cureus. 2024. PMID: 38533160 Free PMC article.
-
Hemoglobin Glycation Index Is Associated With Cardiovascular Diseases in People With Impaired Glucose Metabolism.J Clin Endocrinol Metab. 2017 Aug 1;102(8):2905-2913. doi: 10.1210/jc.2017-00191. J Clin Endocrinol Metab. 2017. PMID: 28541544 Free PMC article.
-
A new metabolomic signature in type-2 diabetes mellitus and its pathophysiology.PLoS One. 2014 Jan 17;9(1):e85082. doi: 10.1371/journal.pone.0085082. eCollection 2014. PLoS One. 2014. PMID: 24465478 Free PMC article.
References
-
- Cohen RM, Holmes YR, Chenier TC, Joiner CH. Discordance between HbA1c and fructosamine: evidence for a glycosylation gap and its relation to diabetic nephropathy. Diabetes Care 2003;26:163–167 - PubMed
-
- Hempe JM, Gomez R, McCarter RJ, Jr, Chalew SA. High and low hemoglobin glycation phenotypes in type 1 diabetes: a challenge for interpretation of glycemic control. J Diabetes Complications 2002;16:313–320 - PubMed
-
- Hudson PR, Child DF, Jones H, Williams CP. Differences in rates of glycation (glycation index) may significantly affect individual HbA1c results in type 1 diabetes. Ann Clin Biochem 1999;36:451–459 - PubMed
-
- Gould BJ, Davie SJ, Yudkin JS. Investigation of the mechanism underlying the variability of glycated haemoglobin in non-diabetic subjects not related to glycaemia. Clin Chim Acta 1997;260:49–64 - PubMed
Publication types
MeSH terms
Substances
LinkOut - more resources
Full Text Sources
Other Literature Sources
Medical
Miscellaneous